Product Categories
| Country: | China |
|---|---|
| Tel: | 180-04525530 |
| Mobile: | 18004525530 |
| E-mail: | |
| QQ: | |
| Skype: | Chat Now! |
| Product Name | MF | CAS | Details |
|---|
| Cell Adhesive Peptide [RGDC] - 1 mg | C15H27N7O7S | 109292-46-8 | Details |
| Caloxin 1B1 - 1 mg | Details |
| Caspase 9 Substrate 1f, fluorogenic - 5 mg | C33H38F3N7O11 | 210345-03-2 | Details |
| Cathepsin K substrate - 0.1 mg | Details |
| Caspase 9 Substrate 1, chromogenic - 5 mg | Details |
| Corticotropin Releasing Factor, CRF, human, rat - 1 mg | C208H344N60O63S2 | 86784-80-7 | Details |
| BSB [(trans,trans)-1-Bromo-2.5-bis-(3-hydroxycarbonyl-4-hydroxy)styrylbenzene] - 5 mg | C28H23NaO6S2 | 56776-28-4 | Details |
| Calcitonin, human | C151H226N40O45S3 | 21215-62-3 | Details |
| Caspase 3 (Apopain) Substrate 1m, fluorogenic - 5 mg | C30H37N5O13 | 169332-61-0 | Details |
| Collagen (Type IV), FAM conjugated - 1 mg | Details |
| Cardiac Ryanodine Receptor RYR2 (2460-2495) - 1 mg | Details |
| Cathepsin S Substrate - 1 mg | C41H66N12O9 | 1135686-31-5 | Details |
| Calcitonin Gene Related Peptide, CGRP (alpha), human | C163H267N51O49S2 | 90954-53-3 | Details |
| CEF2, Influenza Virus PA (46-54) - 1 mg | Details |
| B-type Natriuretic Peptide, BNP-45, mouse - 0.5 mg | 1816939-52-2 | Details |
| Chimeric Rabies Virus Glycoprotein Fragment (RVG-9R) - 1 mg | 1678417-57-6 | Details |
| Calpain Substrate Suc-LLVY-AMC, fluorogenic substrate - 5 mg | C40H53N5O10 | 94367-21-2 | Details |
| Caspase 1 (ICE) Substrate 2, chromogenic - 5 mg | C29H36N6O10 | 149231-66-3 | Details |
| Conantokin G - 0.5 mg | C88H137N25O45 | 133628-78-1 | Details |
| BSA-Biotin Conjugate -10 mg | Details |
| Caspase 1 (ICE) Substrate 3f, fluorogenic - 5 mg | C38H37F3N8O11 | 210344-99-3 | Details |
| BSA-HiLyte Fluor 750 Conjugate -5 mg | Details |
| Caspase 3 (Apopain) Substrate 1r-z, fluorogenic - 5 mg | C72H78N10O27 | 223538-61-2 | Details |
| CEF Control Peptide Pool - 16 mg | Details |
| CEF10, Epstein-Barr Virus LMP2 (426-434) - 1 mg | Details |
| CEF20, Cytomegalovirus, CMV pp65 (495-503) - 1 mg | C42H74N10O12S | 153045-21-7 | Details |
| Caloxin 2A1 - 1 mg | C64H91N19O22 | 350670-85-8 | Details |
| Caspase 1 (ICE) Inhibitor II - 1 mg | C24H33ClN4O8 | 178603-78-6 | Details |
| Cathepsin D and E FRET Substrate - 1 mg | Details |
| CEF25, Influenza Virus NP (44-52) - 1 mg | Details |
| B-type Natriuretic Peptide, BNP-45 (51-95), rat - 0.5 mg | C213H349N71O65S3 | 123337-89-3 | Details |
| Caspase 8 Substrate 1, chromogenic - 5 mg | C27H38N6O12 | 219138-21-3 | Details |
| CMVpp65-4 (SVLGPISGHVLKAVF) - 1 mg | Details |
| Bradykinin, Angiotensin I Converting Enzyme (ACE I) Inhibitor | C50H73N15O11 | 58-82-2 | Details |
| Calcein blue, AM - 1 mg | C21H23NO11 | 168482-84-6 | Details |
| CDK1 Substrate [HATPPKKKRK] - 5 mg | Details |
| Charybdotoxin - 0.1 mg | C176H277N57O55S7 | 95751-30-7 | Details |
| CKS-17 (dimer), MN10021 - 1 mg | C87H148N26O24 | 99273-04-8 | Details |
| ClearPoint beta-Amyloid (1-38), 13C-Phe & Ile - 0.05 mg | Details |
| Calcitonin Gene Related Peptide, CGRP (alpha), human, Biotin-LC-labeled - 1 mg | Details |
| Colivelin - 1 mg | C119H206N32O35 | 867021-83-8 | Details |
| Caerulein, Ceruletide - 1 mg | C58H73N13O21S2 | 17650-98-5 | Details |
| B-PE (B-Phycoerythrin) - 1 mg | Details |
| Caspase 3 (Apopain) Substrate 1f, fluorogenic - 5 mg | C30H34F3N5O13 | 201608-14-2 | Details |
| Caspase 3 (Apopain) Substrate 1f-z, fluorogenic - 5 mg | Details |
| Collagen (Type I), FITC conjugated Water Insoluble - 5 mg | Details |
| Caspase 8 Substrate 1f, fluorogenic - 5 mg | Details |
| CEF26, Influenza Virus NP (265-274) - 1 mg | Details |
| B-type Natriuretic Peptide, BNP-32, human | C143H244N50O42S4 | 114471-18-0 | Details |
| Calcitonin Gene Related Peptide,CGRP (alpha), aCGRP, rat, mouse - 1 mg | C162H262N50O52S2 | 83651-90-5 | Details |
| CEF1, Influenza Matrix Protein M1 (58-66) - 1 mg | C49H75N9O11 | 141368-69-6 | Details |
| C5a Receptor Agonist, mouse, human - 1 mg | Details |
| Caspase 3 (Apopain) Substrate 1, chromogenic - 5 mg | C26H34N6O13 | 189950-66-1 | Details |
| CK1 Peptide Substrate [pS7] [KRRRAL-pS-VASLPGL] - 1 mg | Details |
| CDK5 Substrate [PKTPKKAKKL] - 1 mg | Details |
| Congo Red UltraPure Grade - 1 g | C32H22N6Na2O6S2 | 573-58-0 | Details |
| BrdU [5-Bromo-2’-deoxyuridine] - 25 mg | C9H11BrN2O5 | 59-14-3 | Details |
| Calcein, AM UltraPure Grade, 5 mM solution in anhydrous DMSO - 200 μl | C46H46N2O23 | 148504-34-1 | Details |
| ClearPoint beta-Amyloid (1-40), 13C, 15N-labeled at Arg & Lys - 50 μg | Details |
| C34, gp41 HIV Fragment - 1 mg | Details |
| Cecropin B - 0.5 mg | C176H302N52O41S | 80451-05-4 | Details |
| Collagen (Type I), FITC conjugated Water soluble - 1 mg | Details |
| Cholecystokinin (26-33), CCK8, Non-Sulfated CCK-8 - 1 mg | C49H62N10O13S2 | 25679-24-7 | Details |
| CEF8, Influenza Virus NP (383-391) - 1 mg | Details |
| Cholecystokinin (26-33), CCK8, Sulfated CCK-8 - 1 mg | C49H62N10O16S3 | 25126-32-3 | Details |
| Buforin 2 - 1 mg | C106H184N40O26 | 172998-24-2 | Details |
| C3a (70-77) - 1 mg | C35H61N13O10 | 63555-63-5 | Details |
| Cell Permeable-Mastoparan Peptide | C70H131N19O15 | 72093-21-1 | Details |
| Calcitonin, salmon - 5 mg | C145H240N44O48S2 | 47931-85-1 | Details |
| Chlorotoxin (Cltx) - 0.1 mg | C158H249N53O47S11 | 163515-35-3 | Details |
| Caloxin 3A1 - 1 mg | Details |
| CFP10 (71–85) - 1 mg | Details |
| Cecropin A Peptide | C184H313N53O46 | 80451-04-3 | Details |
| Corticotropin Releasing Factor, CRF, ovine - 0.5 mg | C205H339N59O63S | 79804-71-0 | Details |
| Bradykinin Antagonist, HOE I40 - 1 mg | C59H89N19O13S | 130308-48-4 | Details |
| CEF30, Epstein-Barr Virus BRLF1 (134-142) - 1 mg | Details |
| Cls Substrate, C2 (5-FAM/ QXL? 520) - 0.5 mg | Details |
| c-Myc peptide epitope | C43H69N11O14 | Details |
| ClearPoint BSA (347-359), Isotopic labeled, Mass Spec Standard - 0.1 mg | Details |
| Calpain Inhibitor Peptide, B27-WT - 0.5 mg | C140H227N35O44S | 128578-18-7 | Details |
| Calcitonin Gene Related Peptide, CGRP (alpha) (8-37), human - 1 mg | C139H230N44O38 | 119911-68-1 | Details |
| Calpain Substrate, Fluorogenic, (Z-AA)2Rh110 - 5 mg | Details |
| Calcitonin Gene Related Peptide, CGRP (beta), human - 0.5 mg | C162-H267-N51O48S3 | 101462-82-2 | Details |
| Caspase 1 (ICE) Inhibitor II, biotinylated - 1 mg | Details |
| Casein Kinase 2 (CK2) Substrate alpha-subunit [RRRDDDSDDD] - 1 mg | Details |
| CAP-18, rabbit - 0.5 mg | Details |
| Cls Substrate, C2 (Abz/Dnp) - 1 mg | Details |
| CEF Control Peptide Pool - 1 mg | Details |
| CDK7/9 tide [YSPTSPSYSPTSPSYSPTSPSKKKK] - 1 mg | Details |
| CL-APC (Cross Linked-Allophycocyanin) - 1 mg | Details |
| Chemerin (149-157) - 1 mg | Details |
| CEF11, Epstein-Barr Virus BMLF1 (280-288) - 1 mg | Details |
| ClearPoint beta-Amyloid (1-42), 13C, 15N-labeled at Arg & Lys - 50 μg | Details |
| CEF19, Epstein-Barr Virus latent NA-3A (458-466) - 1 mg | Details |
| BSA-HiLyte Fluor 647 Conjugate -5 mg | Details |
| CEF Control Peptide Pool - 8 mg | Details |
| Collagen alpha1(I) C-Telopeptide (614-639), human - 1 mg | Details |
| C5a Receptor Antagonist, linear, human, rat - 1 mg | Details |
| BSA-HiLyte Fluor 488 Conjugate -5 mg | Details |
| BSA-HiLyte Fluor 555 Conjugate -5 mg | Details |
| Product Total： Product Page： | ||||
| 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 | ||||